ArticleGMS hygiene and infection control2025
Hyperendemicity and genotype diversity of hepatitis B virus among patients attending the University of Abuja Teaching Hospital, Nigeria.
Article in GMS hygiene and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatitis B virus (HBV) infection remains a significant global public health issue, particularly in sub-Saharan Africa, due to inadequate healthcare and research into its genetic epidemiology. This study aims to determine the frequency of HBV antigens, antibodies, and genotypes among febrile patients attending the University of Abuja Teaching Hospital (UATH), Nigeria. Methods: This cross-sectional study enrolled 100 patients, whose blood samples were collected and screened for HBV surface antigen (HBsAg) and four other structural antigens and antibodies by Lateral Flow Assay. All HBsAg-positive samples were genotyped using type-specific polymerase chain reactions. Structured questionnaires were used to collate the sociodemographic variables of the patients. Results: HBsAg-seropositivity was 31%. The distribution of HBV genotypes was as follows: genotype E was predominant (22.6%), followed by genotype B (16.1%). Of the HBsAg-positive individuals, all were HBsAb-seronegative, 3.2%, 74.2%, and 90.3% were HBeAg, HbeAb, and HBcAb seropositive, respectively. Genotypes B, C, and D were detected in 16.1%, 3.2%, and 3.2%, respectively. Based on the number of HBV genotypes per individual, 9.7% had a single genotype, 16.1% had double genotypes, and 74.2% had triple genotypes. Higher educational qualification was significantly associated with triple HBV genotypes per individual ( Conclusion: Very high seroprevalence of HBV was found and genotype E predominated. The presence of within-host multiple HBV genotypes was identified for the first time in Nigeria. This indicates the genetic heterogeneity of HBV in northern Nigeria and suggests potential effects on the control measures available.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.